These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16436648
1. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF, Topiramate Essential Tremor Study Investigators. Neurology; 2006 Mar 14; 66(5):672-7. PubMed ID: 16436648 [Abstract] [Full Text] [Related]
6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group. Clin Ther; 2009 Mar 14; 31(3):542-59. PubMed ID: 19393844 [Abstract] [Full Text] [Related]
7. The impact of topiramate on health-related quality of life indicators in chronic migraine. Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ. Headache; 2007 Mar 14; 47(10):1398-408. PubMed ID: 18052949 [Abstract] [Full Text] [Related]
8. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group. Int J Obes Relat Metab Disord; 2004 Nov 14; 28(11):1399-410. PubMed ID: 15486569 [Abstract] [Full Text] [Related]
12. Long-term migraine prevention with topiramate: open-label extension of pivotal trials. Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J. Headache; 2006 Oct 14; 46(7):1151-60. PubMed ID: 16866719 [Abstract] [Full Text] [Related]
13. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J, TRS study group. Mov Disord; 2007 Apr 30; 22(6):833-8. PubMed ID: 17343274 [Abstract] [Full Text] [Related]
14. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S. Bipolar Disord; 2007 Sep 30; 9(6):609-17. PubMed ID: 17845276 [Abstract] [Full Text] [Related]
15. The impact of migraine on daily activities: effect of topiramate compared with placebo. Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. Curr Med Res Opin; 2006 Jun 30; 22(6):1021-9. PubMed ID: 16846536 [Abstract] [Full Text] [Related]
16. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Kushner SF, Khan A, Lane R, Olson WH. Bipolar Disord; 2006 Feb 30; 8(1):15-27. PubMed ID: 16411977 [Abstract] [Full Text] [Related]
17. Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials. Chang KH, Wang SH, Chi CC. Medicine (Baltimore); 2015 Oct 30; 94(43):e1809. PubMed ID: 26512577 [Abstract] [Full Text] [Related]